| Name | Title | Contact Details |
|---|---|---|
Todd Leri |
Chief Growth Officer | Profile |
Kevin Kenney |
SVP of Growth and Client Success | Profile |
Mike Tudeen |
Chief Executive Officer | Profile |
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Camarillo Health Care District is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Camarillo, CA. To find more information about Camarillo Health Care District, please visit www.camhealth.com
Healthcare Resource Network is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Black Womens Health Imperative, previously the National Black Womens Health Project, was formed in 1984 in Atlanta, Georgia out of a need to address the health and reproductive rights of African American women.
Children's Harbor Family Ctr is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.